原发性醛固酮增多症
医学
亚临床感染
盐皮质激素受体
重症监护医学
继发性高血压
不利影响
疾病
醛固酮
醛固酮增多症
肾脏疾病
血压
生物信息学
内科学
盐皮质激素
醛固酮合酶
观察研究
前瞻性队列研究
系统回顾
原发性高血压
荟萃分析
梅德林
病因学
内分泌疾病
螺内酯
内分泌系统
心脏病学
内分泌学
治疗方法
临床试验
标识
DOI:10.3389/fendo.2026.1899618
摘要
Primary aldosteronism (PA) has traditionally been considered a rare cause of secondary hypertension, but growing evidence supports a broader continuum of renin-independent aldosterone production extending into normotensive and mildly hypertensive populations. Subclinical primary aldosteronism (SPA) has emerged as a conceptual framework describing this milder phenotype. However, a universally accepted definition of SPA remains lacking, and consensus diagnostic criteria have yet to be established. This review synthesizes current evidence regarding SPA, including its epidemiology, pathophysiology, clinical implications, diagnostic challenges, and potential therapeutic strategies. Low-renin phenotypes are observed in a substantial proportion of individuals, although the true prevalence of SPA remains uncertain due to the lack of consensus diagnostic criteria. Observational studies have associated SPA with adverse cardiovascular and renal outcomes, including arterial stiffness, adverse cardiac remodeling, major adverse cardiovascular events, albuminuria, and chronic kidney disease progression, with effects not fully explained by blood pressure elevation alone. Conventional screening strategies based on the aldosterone-to-renin ratio have limitations in detecting this subclinical spectrum. Mineralocorticoid receptor antagonists and aldosterone synthase inhibitors represent hypothesis-generating therapeutic strategies, although prospective interventional evidence in SPA populations is lacking. At present, SPA should be regarded as an emerging risk-associated biochemical phenotype rather than an established disease category, pending prospective validation. Future studies are needed to determine whether consensus diagnostic criteria can be established and to validate clinically applicable screening strategies for this emerging endocrine phenotype.
科研通智能强力驱动
Strongly Powered by AbleSci AI